...
首页> 外文期刊>Asia-Pacific Biotech News >Japan Generic Drug Market Surge due to Government Incentives
【24h】

Japan Generic Drug Market Surge due to Government Incentives

机译:日本仿制药物市场飙升因政府激励措施

获取原文
获取原文并翻译 | 示例

摘要

Unlike their counterparts in the US, Germany or Britain, people in japan seldom ask for the cheaper generic drugs in the pharmacy. However, due to the change in government financial incentives to ease its spiraling medical costs, the country's genericdrug market is expected to boom in the near future. New drugs, like other new products, are developed under patent protection such that the company will have the sole right to sell the drug while the patent is in effect When patents expire, other manufacturers can apply to sell generic versions. A generic drug is identical to its original prescription drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. They are usually sold at lower prices than the branded ones.
机译:与美国,德国或英国的同行不同,日本人民很少地要求药房的更便宜的普通药物。 然而,由于政府财务激励的变化,为了缓解其螺旋性医疗费用,预计该国的常规推动市场将在不久的将来繁荣。 新的药物与其他新产品一样,是在专利保护下制定的,使得公司将有唯一的销售药物的权利,而专利在专利到期时,其他制造商可以申请出售通用版本。 通用药物与其原始处方药中的剂型,安全性,强度,给药途径,质量,性能特征和预期用途相同。 它们通常以较低的价格出售而不是品牌的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号